2021 ESGO指南:晚期卵巢癌减瘤手术的围术期管理

2021-08-18 欧洲妇科肿瘤学会 Int J Gynecol Cancer.2021 Aug 18;

欧洲妇科肿瘤学会 (ESGO) 于 2016 年首次制定并建立,并于 2020 年更新晚期卵巢癌手术的质量指标,以审核和改善欧洲及其他地区的临床实践。作为不断努力改善卵巢癌患者肿瘤治疗的后遗症,ESG

中文标题:

2021 ESGO指南:晚期卵巢癌减瘤手术的围术期管理

英文标题:

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

发布机构:

欧洲妇科肿瘤学会

发布日期:

2021-08-18

简要介绍:

欧洲妇科肿瘤学会 (ESGO) 于 2016 年首次制定并建立,并于 2020 年更新晚期卵巢癌手术的质量指标,以审核和改善欧洲及其他地区的临床实践。作为不断努力改善卵巢癌患者肿瘤治疗的后遗症,ESGO 于 2018 年与欧洲肿瘤内科学会联合发布了一份共识指南,以多学科方式解决了卵巢癌治疗中的 20 个选定关键问题,包括缓解原发性和复发性疾病的分子病理学。为了补充上述成就并通过充分的围手术期管理巩固促进的系统进步和外科专业知识,作为下一步,ESGO 制定了临床相关和循证指南,重点关注围手术期护理和管理的关键方面作为其使命的一部分,改善晚期卵巢癌妇女的护理质量并降低医源性发病率。为此,ESGO 提名了一个国际多学科发展小组,该小组由在卵巢癌护理和研究方面表现出领导力和专业知识的执业临床医生和研究人员组成(欧洲有 18 位专家)。为确保指南以证据为基础,对 2015 年以来发表的文献进行了系统检索,并对其进行了严格评价。在没有任何明确的科学证据的情况下,判断是基于开发组的专业经验和共识。因此,该指南基于现有的最佳证据和专家协议。在发布之前,指南由 117 位独立的国际癌症护理从业人员和患者代表进行了审查。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESGO指南:晚期卵巢癌减瘤手术的围术期管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=27d001c00216266f, title=2021 ESGO指南:晚期卵巢癌减瘤手术的围术期管理, enTitle=European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery, guiderFrom=Int J Gynecol Cancer.2021 Aug 18;, authorId=0, author=, summary=欧洲妇科肿瘤学会 (ESGO) 于 2016 年首次制定并建立,并于 2020 年更新晚期卵巢癌手术的质量指标,以审核和改善欧洲及其他地区的临床实践。作为不断努力改善卵巢癌患者肿瘤治疗的后遗症,ESG, cover=https://img.medsci.cn/2021827/1629993718821_2020535.jpg, journalId=0, articlesId=null, associationId=1422, associationName=欧洲妇科肿瘤学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="bp3-card bp3-elevation-0 result-block" style="color: #182026;"> <div class="bp3-collapse"> <div class="bp3-collapse-body bp3-fixed-positioning-containing-block" aria-hidden="false"> <div class="common-result"> <div class="general-result"> <p>欧洲妇科肿瘤学会 (ESGO) 于 2016 年首次制定并建立,并于 2020 年更新晚期卵巢癌手术的质量指标,以审核和改善欧洲及其他地区的临床实践。作为不断努力改善卵巢癌患者肿瘤治疗的后遗症,ESGO 于 2018 年与欧洲肿瘤内科学会联合发布了一份共识指南,以多学科方式解决了卵巢癌治疗中的 20 个选定关键问题,包括缓解原发性和复发性疾病的分子病理学。为了补充上述成就并通过充分的围手术期管理巩固促进的系统进步和外科专业知识,作为下一步,ESGO 制定了临床相关和循证指南,重点关注围手术期护理和管理的关键方面作为其使命的一部分,改善晚期卵巢癌妇女的护理质量并降低医源性发病率。为此,ESGO 提名了一个国际多学科发展小组,该小组由在卵巢癌护理和研究方面表现出领导力和专业知识的执业临床医生和研究人员组成(欧洲有 18 位专家)。为确保指南以证据为基础,对 2015 年以来发表的文献进行了系统检索,并对其进行了严格评价。在没有任何明确的科学证据的情况下,判断是基于开发组的专业经验和共识。因此,该指南基于现有的最佳证据和专家协议。在发布之前,指南由 117 位独立的国际癌症护理从业人员和患者代表进行了审查。<button class="bp3-button bp3-minimal bp3-small" style="color: #182026;" title="朗读" type="button"></button></p> </div> </div> </div> </div> </div> <div class="external-translators" style="color: #182026;"> <div>&nbsp;</div> </div>, tagList=[TagDto(tagId=359, tagName=卵巢癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=359, guiderKeyword=卵巢癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12201, appHits=170, showAppHits=0, pcHits=934, showPcHits=12028, likes=1, shares=13, comments=8, approvalStatus=1, publishedTime=Sun Aug 29 22:36:28 CST 2021, publishedTimeString=2021-08-18, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 27 00:02:06 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Wed Jan 03 19:59:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESGO指南:晚期卵巢癌减瘤手术的围术期管理.pdf)])
2021 ESGO指南:晚期卵巢癌减瘤手术的围术期管理.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195825, encodeId=9c3711958254c, content=好,要是能带翻译就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28fc5181510, createdName=146f9bcbm81暂无昵称, createdTime=Mon Feb 21 20:49:34 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085661, encodeId=05d11085661bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:07:17 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066881, encodeId=b19f1066881c4, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Thu Nov 04 11:29:25 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052253, encodeId=415f1052253aa, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011962, encodeId=362d10119622d, content=你最可爱了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:10:55 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2022-02-21 146f9bcbm81暂无昵称

    好,要是能带翻译就好了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195825, encodeId=9c3711958254c, content=好,要是能带翻译就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28fc5181510, createdName=146f9bcbm81暂无昵称, createdTime=Mon Feb 21 20:49:34 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085661, encodeId=05d11085661bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:07:17 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066881, encodeId=b19f1066881c4, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Thu Nov 04 11:29:25 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052253, encodeId=415f1052253aa, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011962, encodeId=362d10119622d, content=你最可爱了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:10:55 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-12-30 D-House

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1195825, encodeId=9c3711958254c, content=好,要是能带翻译就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28fc5181510, createdName=146f9bcbm81暂无昵称, createdTime=Mon Feb 21 20:49:34 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085661, encodeId=05d11085661bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:07:17 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066881, encodeId=b19f1066881c4, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Thu Nov 04 11:29:25 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052253, encodeId=415f1052253aa, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011962, encodeId=362d10119622d, content=你最可爱了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:10:55 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-11-04 1e167f5cm82(暂无匿称)

    好的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195825, encodeId=9c3711958254c, content=好,要是能带翻译就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28fc5181510, createdName=146f9bcbm81暂无昵称, createdTime=Mon Feb 21 20:49:34 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085661, encodeId=05d11085661bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:07:17 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066881, encodeId=b19f1066881c4, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Thu Nov 04 11:29:25 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052253, encodeId=415f1052253aa, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011962, encodeId=362d10119622d, content=你最可爱了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:10:55 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-09-17 H8888888

    文章不错 谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1195825, encodeId=9c3711958254c, content=好,要是能带翻译就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28fc5181510, createdName=146f9bcbm81暂无昵称, createdTime=Mon Feb 21 20:49:34 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085661, encodeId=05d11085661bc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Thu Dec 30 04:07:17 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066881, encodeId=b19f1066881c4, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Thu Nov 04 11:29:25 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052253, encodeId=415f1052253aa, content=文章不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Sep 17 09:19:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011962, encodeId=362d10119622d, content=你最可爱了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Fri Aug 27 10:10:55 CST 2021, time=2021-08-27, status=1, ipAttribution=)]
    2021-08-27 查查佳佳

    你最可爱了

    0

拓展阅读

2010ESMO临床实践指南:非上皮性卵巢癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01

2011 NICE 卵巢癌的诊断和起始治疗

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011 NICE Trabectedin治疗复发性卵巢癌

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2012 ESMO临床实践指南:非上皮性卵巢癌的诊治与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2012 NSGC实践指南:遗传性乳腺癌和卵巢癌的风险评估和遗传咨询

国家遗传咨询师学会(NSGC,National Society of Genetic Counselors) · 2012-11-28

2013 FIGO 卵巢癌、输卵管癌、腹膜癌分期指南

国际妇产科联盟(FIGO,International Federation of Gynecology and Obstetrics) · 2013-10-22